Kapitalforeningen Accunia Invest
Meddelelse om at der er foretaget ændringer i prospekterne for:
• Accunia Invest EUR CLO Opportunity KL, ACAECO, DK0060804052
• Accunia Invest EUR CLO Invest Grade DKK, ACACIGDKK, DK0060804136
• Accunia Invest European High Yield (KL), ACKEHY, DK0061149036
Der er foretaget følgende ændring:
• Som følge af den nye forordning om bæredygtighedsrelaterede oplysninger (SFDR), der træder i kraft den 10.marts 2021, er der indsat et afsnit med bæredygtighedsrelaterede oplysninger.
Kontaktperson:
Direktør Caspar Møller, tlf. +45 3332 7070.
Yderligere oplysninger om Kapitalforeningen Accunia Invest findes på www.accunia-invest.dk.
Store Regnegade 5, 1, 1110 København K, tlf. 33 32 70 70
contact@accunia.com
Attachments
- §62-dok - EuroCLO.IG - AccInvKF (mar'21)
- §62-dok - EuroCLO.OPP - AccInvKF (mar'21)
- §62-dok - EuroHY - AccInvKF (mar'21)
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Yacht Club de Monaco9.1.2026 09:05:00 CET | Press release
At the Yacht Club de Monaco a year of transition and innovation begins
Onco3R Therapeutics BV9.1.2026 09:00:00 CET | Press release
O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated
Zealand Pharma9.1.2026 08:00:00 CET | Press release
Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy
Sparinvest SICAV9.1.2026 08:00:00 CET | Pressemeddelelse
Finanskalender for Sparinvest SICAV
Sampo plc9.1.2026 07:30:00 CET | Press release
Sampo plc’s share buybacks 8 January 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom